BlackRock’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $63.3M | Buy |
|
|||||
|
2025
Q2 | $41.4M | Sell |
|
|||||
|
2025
Q1 | $30.3M | Buy |
|
|||||
|
2024
Q4 | $41.3M | Buy |
|
|||||
|
2024
Q3 | $52.3M | Buy |
|
|||||
|
2024
Q2 | $34.2M | Buy |
|
|||||
|
2024
Q1 | $43.7M | Buy |
|
|||||
|
2023
Q4 | $28.5M | Sell |
|
|||||
|
2023
Q3 | $22.6M | Buy |
|
|||||
|
2023
Q2 | $20M | Buy |
|
|||||
|
2023
Q1 | $3.94M | Sell |
|
|||||
|
2022
Q4 | $4.7M | Sell |
|
|||||
|
2022
Q3 | $3.32M | Buy |
|
|||||
|
2022
Q2 | $3.58M | Sell |
|
|||||
|
2022
Q1 | $12.7M | Sell |
|
|||||
|
2021
Q4 | $35.5M | Buy |
|
|||||
|
2021
Q3 | $50.4M | Buy |
|
|||||
|
2021
Q2 | $40.2M | Buy |
|
|||||
|
2021
Q1 | $46.8M | Buy |
|
|||||
|
2020
Q4 | $63.6M | Buy |
|
|||||
|
2020
Q3 | $19.4M | Sell |
|
|||||
|
2020
Q2 | $29.3M | Buy |
|